Survival in frontotemporal dementia

Neurology

Volumn 61, Issue 3, 2003, Pages 349-354

  Hodges, John ^a,b   Davies, R ^a   Xuereb, J ^a   Kril, J ^d   Halliday, G ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APHASIA; ARTICLE; AUSTRALIA; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEATH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; INSTITUTIONAL CARE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MOTOR NEURON DISEASE; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; SEMANTICS; SURVIVAL RATE; SURVIVAL TIME;

EID: 0042626056     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000078928.20107.52     Document Type: Article

References (28)

1. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996;91:127-134.
2. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol 2001;58:1803-1809.
3. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
4. Hodges JR, Miller B. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topics papers: Part 1. Neurocase 2001;7:31-35.
5. Grossman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc 2002;8:566-583.
6. Bak TH, Hodges JR. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol 2001;248:260-270.
7. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368-1375.
8. Mathuranath PS, Xuereb JH, Bak T, Hodges JR. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 2000;68:304-312.
9. Harvey RJ. Epidemiology of presenile dementia. In: Hodges JR, ed. Early-onset dementia: a multidisciplinary approach. Oxford: Oxford University Press, 2001;1-23.
10. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58:1615-1621.
11. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
12. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18(suppl 4): S1-S2.
13. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
14. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2): II6-II15.
15. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57:129-133.
16. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
17. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002;61:547-556.
18. Binetti G, Locascio JJ, Corkin S, BVonsattel JP, Growden JH. Differences between Pick disease and Alzheimer disease in clinical appearance and the rate of cognitive decline. Arch Neurol 2000;57:225-232.
19. Stevens M, van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology 1998;50:1541-1545.
20. Poorkaj P, Grossman M, Steinbart E, et al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001;58:383-387.
21. Forman MS, Zhukareva V, Bergeron C, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 2002;160:2045-2053.
22. Hanger DP, Gibb GM, de Silva R, et al. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett 2002;531:538-542.
23. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608-1615.
24. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001;344:1111-1116.
25. Claus JJ, van Gool WA, Teunisse S, et al. Predicting survival in patients with early Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9:284-293.
26. Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF. Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol 2001;154:642-648.
27. Newens AJ, Forster DP, Kay DW, Kirkup W, Bates D, Edwardson J. Clinically diagnosed presenile dementia of the Alzheimer type in the Northern Health Region: ascertainment, prevalence, incidence and survival. Psychol Med 1993;23:631-644.
28. Thomas BM, McGonigal G, McQuade CA, Starr JM, Whalley LJ. Survival in early onset dementia: effects of urbanization and socioeconomic deprivation. Neuroepidemiology 1997;16:134-140.